11-25077393-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001009909.4(LUZP2):c.923A>G(p.Glu308Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E308Q) has been classified as Likely benign.
Frequency
Consequence
NM_001009909.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LUZP2 | NM_001009909.4 | c.923A>G | p.Glu308Gly | missense_variant | 11/12 | ENST00000336930.11 | |
LUZP2 | NM_001252010.2 | c.797A>G | p.Glu266Gly | missense_variant | 9/10 | ||
LUZP2 | NM_001252008.2 | c.665A>G | p.Glu222Gly | missense_variant | 11/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LUZP2 | ENST00000336930.11 | c.923A>G | p.Glu308Gly | missense_variant | 11/12 | 1 | NM_001009909.4 | P1 | |
LUZP2 | ENST00000533227.5 | c.665A>G | p.Glu222Gly | missense_variant | 11/12 | 1 | |||
LUZP2 | ENST00000620308.1 | c.665A>G | p.Glu222Gly | missense_variant | 10/11 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 28
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 29, 2024 | The c.923A>G (p.E308G) alteration is located in exon 11 (coding exon 11) of the LUZP2 gene. This alteration results from a A to G substitution at nucleotide position 923, causing the glutamic acid (E) at amino acid position 308 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.